長遠鋰科(688779.SH)一季度淨利潤預增143%到177.72%
格隆匯3月27日丨長遠鋰科(688779.SH)公佈,公司預計公司2022年第一季度營業收入為33.5億元到34.5億元,與上年同期(法定披露數據)相比,同比增長175.77%到184%。
公司預計2022年第一季度實現歸屬於母公司所有者的淨利潤為2.8億元到3.2億元,與上年同期(法定披露數據)相比,同比增長143%到177.72%。
業績變化的主要原因:1、公司車用鋰電池正極材料擴產一期項目建成投產,報吿期內新建產能逐步釋放,產品產銷量實現增長。且市場需求旺盛推動產品價格上漲,公司營業收入大幅增加。2、隨着公司產能規模擴張,規模效應下公司成本控制能力進一步提升,淨利潤實現增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.